[go: up one dir, main page]

Leemans et al., 2022 - Google Patents

Volatile organic compounds analysis as a potential novel screening tool for breast cancer: a systematic review

Leemans et al., 2022

View HTML
Document ID
6579743380701374929
Author
Leemans M
Bauër P
Cuzuel V
Audureau E
Fromantin I
Publication year
Publication venue
Biomarker Insights

External Links

Snippet

Introduction: An early diagnosis is crucial in reducing mortality among people who have breast cancer (BC). There is a shortfall of characteristic early clinical symptoms in BC patients, highlighting the importance of investigating new methods for its early detection. A …
Continue reading at journals.sagepub.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infra-red light
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Leemans et al. Volatile organic compounds analysis as a potential novel screening tool for breast cancer: a systematic review
Markar et al. Assessment of a noninvasive exhaled breath test for the diagnosis of oesophagogastric cancer
Hanna et al. Accuracy and methodologic challenges of volatile organic compound–based exhaled breath tests for cancer diagnosis: a systematic review and meta-analysis
Koureas et al. Target analysis of volatile organic compounds in exhaled breath for lung cancer discrimination from other pulmonary diseases and healthy persons
Bax et al. Innovative diagnostic methods for early prostate cancer detection through urine analysis: A review
Scheepers et al. Diagnostic performance of electronic noses in cancer diagnoses using exhaled breath: A systematic review and meta-analysis
Di Gilio et al. Breath analysis: Comparison among methodological approaches for breath sampling
Wen et al. Urinary volatile organic compound analysis for the diagnosis of cancer: A systematic literature review and quality assessment
Boots et al. Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises
Cavaco et al. Screening of salivary volatiles for putative breast cancer discrimination: An exploratory study involving geographically distant populations
Amann et al. Lung cancer biomarkers in exhaled breath
Rydosz A negative correlation between blood glucose and acetone measured in healthy and type 1 diabetes mellitus patient breath
Jung et al. Advanced diagnostic technology of volatile organic compounds real time analysis analysis from exhaled breath of gastric cancer patients using proton-transfer-reaction time-of-flight mass spectrometry
Tanaka et al. Clinical assessment of oral malodor by the electronic nose system
Tzatzarakis et al. Hair nicotine/cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults
Mallafre-Muro et al. Comprehensive volatilome and metabolome signatures of colorectal cancer in urine: a systematic review and meta-analysis
Capelli et al. Optimization of training and measurement protocol for eNose analysis of urine headspace aimed at prostate cancer diagnosis
CN109416360A (en) Generation and Use of Biomarker Databases
Ahmed et al. Metabolic signatures of lung cancer in sputum and exhaled breath condensate detected by 1H magnetic resonance spectroscopy: a feasibility study
Bassi et al. Improved non-invasive diagnosis of bladder cancer with an electronic nose: a large pilot study
Riccio et al. Mapping of urinary volatile organic compounds by a rapid analytical method using gas chromatography coupled to ion mobility spectrometry (GC–IMS)
Matsumoto et al. Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study
Rončević et al. MALDI imaging mass spectrometry of high-grade gliomas: a review of recent progress and future perspective
Kononova et al. Breath fingerprint of colorectal cancer patients based on the gas chromatography–mass spectrometry analysis
Gourin et al. Serum protein profile analysis in patients with head and neck squamous cell carcinoma